In this Chapter, we will explore the following topics:
-
Biotech vs pharma - what’s the difference?
-
So how profitable *is* the biopharma industry?
-
Investors: “Don’t have money? We’ll give it to you…but only if it’s worth our while.”
-
Who are investors?
-
Why do we need investors? Doesn’t the NIH fund drug discovery and development?
-
Why would investors hand out money like this?
-
-
The investor’s perspective on funding a new medicine.
-
How VCs think about and evaluate investment opportunities in biotech
-
Calculating Net Present Value (NPV) and its significance in investment decisions
-
Role of VCs in driving innovation and shaping the pharmaceutical landscape
-